Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  melphalan
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 333 for your search:
Start Over
PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20050100, NCT00352703
Oral Zinc Therapy for the Prevention of Mucositis
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: SHEBA-06-4196-MKM-CTIL, NCT00449592
AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-00055-18, NCT00415103
Chemotherapy with 5-FU, Streptozotocin, Spironolactone and L-PAM for Advanced Nonmeasurable Pancreatic Carcinoma (Summary last modified 06/97 ko)
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-5274, MAYO-706031
Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Under 30
Sponsor: NCI, Other
Protocol IDs: AHOD0121, CDR0000330135, COG-AHOD0121, NCT00070187
Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: UARK 2003-26, NCT00090493
Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 19 and over
Sponsor: Other
Protocol IDs: 01-002-0601, NCT00205751
Assessment of Molecular Remission by ASO-qPCR After Bortezomib-dexamethasone (Vel/Dex) Followed by ASCT
Phase: Phase III, Phase II
Type: Diagnostic, Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: R08096M, 2008-003936-38, 26866138MMY2063, NCT00861250
Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Closed
Age: Any Age
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDX-353-002, NCT01660633
Phase III Study of L-PAM/PRED plus Interferon vs L-PAM/PRED Alone in Patients with Multiple Myeloma Who Have Responded to L-PAM/PRED (Summary Last Modified 09/91)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-NCIC-MY6, NCI-V87-0197, MY6
Phase III Chemotherapy with L-PAM Followed by HAD (HMM/ADR/CACP) vs CHAD (CTX/ADR/HMM/CACP) for Advanced Adenocarcinoma of the Ovary
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2878
Phase III Chemotherapy with L-PAM vs ADR/CTX vs HMM/L-PAM for Ovarian Adenocarcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-22
Phase III L-PAM/5-FU/MEG Chemotherapy vs ADR/CTX/5-FU/MEG for Primary Stage III or IV Recurrent or Residual Endometrial Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-28, GOG-7741
Phase III Comparison of Melphalan vs Vinorelbine in Women with Anthracycline-Resistant Breast Cancer (Summary Last Modified 05/91)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: BW-P70-34972-01, NCI-V91-0068
IRS Study IV: Phase III Comparison of VM (VCR/L-PAM) vs IE (IFF/VP-16) vs ID (IFF/DOX) in Patients with Stage 4 Rhabdomyosarcoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21 at diagnosis
Sponsor: NCI
Protocol IDs: IRS-IV-STAGE/GROUP-4, CCG-6903, POG-9152, INT-0119
Phase III Randomized Study of Hyperthermic Isolated Limb Perfusion with L-PAM vs L-PAM/TNF/IFN-G in Patients with Stage IIIA/IIIAB Malignant Melanoma Confined to an Extremity
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UPCC-3695, NCI-92-C-0105H, NCI-T91-0238D, T91-0238
Start Over